Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib DataExelixis, Inc. (NASDAQ: EXEL) | Delayed: 23.38 +0.51 (2.23%) | |||||
---|---|---|---|---|---|---|
Previous Close | $22.87 | 52 Week High | $17.00 | |||
Open | $23.02 | 52 Week Low | $3.55 | |||
Day High | $23.44 | P/E | N/A | |||
Day Low | $23.00 | EPS | $-1.33 | |||
Volume | 574,283 |